{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:02:10Z","timestamp":1761580930542,"version":"3.38.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,11,3]],"date-time":"2011-11-03T00:00:00Z","timestamp":1320278400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s00210-011-0698-7","type":"journal-article","created":{"date-parts":[[2011,11,2]],"date-time":"2011-11-02T15:57:22Z","timestamp":1320249442000},"page":"325-335","source":"Crossref","is-referenced-by-count":11,"title":["Enantioselective pharmacokinetic and pharmacodynamic properties of carvedilol in spontaneously hypertensive rats: focus on blood pressure variability"],"prefix":"10.1007","volume":"385","author":[{"given":"Facundo Mart\u00edn","family":"Bertera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julieta Sof\u00eda","family":"Del Mauro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Chiappetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariel H\u00e9ctor","family":"Polizio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabi\u00e1n","family":"Buontempo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Alberto","family":"Taira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"H\u00f6cht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,11,3]]},"reference":[{"key":"698_CR1","first-page":"208","volume":"4","author":"FM Abboud","year":"1982","unstructured":"Abboud FM (1982) The sympathetic system in hypertension. State of the art review. Hypertension 4:208\u2013225","journal-title":"Hypertension"},{"key":"698_CR2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1161\/01.HYP.14.2.191","volume":"14","author":"MA Adams","year":"1989","unstructured":"Adams MA, Bobik A, Korner PI (1989) Differential development of vascular and cardiac hypertrophy in genetic hypertension. Relation to sympathetic function. Hypertension 14:191\u2013202","journal-title":"Hypertension"},{"issue":"1","key":"698_CR3","first-page":"1","volume":"7","author":"LD Aimone","year":"2005","unstructured":"Aimone LD (2005) Overview of pharmacokinetics. Curr Protoc Pharmacol 7(1):1\u201326","journal-title":"Curr Protoc Pharmacol"},{"issue":"Suppl. 2","key":"698_CR4","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1007\/BF01409475","volume":"38","author":"W Bartsch","year":"1990","unstructured":"Bartsch W, Sponer G, Strein K, M\u00fcller-Beckmann B, Kling L, B\u00f6hm E, Martin U, Borbe HO (1990) Pharmacological characteristics of the stereoisomers of carvedilol. Eur J Clin Pharmacol 38(suppl 2):S104\u2013S107","journal-title":"Eur J Clin Pharmacol"},{"key":"698_CR5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.vascn.2008.10.001","volume":"59","author":"FM Bertera","year":"2009","unstructured":"Bertera FM, Di Verniero CA, Mayer MA, Bramuglia GF, Taira CA, H\u00f6cht C (2009) Is urethane-chloralose anaesthesia appropriate for pharmacokinetic-pharmacodynamic assessment? Studies with carvedilol. J Pharmacol Toxicol Methods 59:13\u201320","journal-title":"J Pharmacol Toxicol Methods"},{"key":"698_CR6","doi-asserted-by":"crossref","unstructured":"Bertera FM, Di Verniero CA, Mayer MA, Chiappetta D, Buontempo F, Polizio AH, Taira CA, H\u00f6cht C (2011) Pharmacokinetic and pharmacodynamic properties of carvedilol in fructose hypertensive rats. Xenobiotica (in press)","DOI":"10.3109\/00498254.2011.604746"},{"key":"698_CR7","volume-title":"ADAPT II User\u2019s guide: pharmacokinetic\/pharmacodynamic systems analysis software","author":"DZ D\u2019Argenio","year":"1997","unstructured":"D\u2019Argenio DZ, Schumitzky A (1997) ADAPT II User\u2019s guide: pharmacokinetic\/pharmacodynamic systems analysis software. Biomedical Simulations Resource, Los Angeles"},{"key":"698_CR8","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1211\/jpp.62.07.0010","volume":"62","author":"CA Verniero Di","year":"2010","unstructured":"Di Verniero CA, Bertera F, Buontempo F, Bernabeu E, Chiappetta D, Mayer MA, Bramuglia GF, Taira CA, H\u00f6cht C (2010) Enantioselective pharmacokinetic-pharmacodynamic modelling of carvedilol in a N-nitro-l-arginine methyl ester rat model of secondary hypertension. J Pharm Pharmacol 62:890\u2013900","journal-title":"J Pharm Pharmacol"},{"key":"698_CR9","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1152\/japplphysiol.01142.2007","volume":"104","author":"R Fazan Jr","year":"2008","unstructured":"Fazan R Jr, Huber DA, Silva CA, Dias da Silva VJ, Salgado MC, Salgado HC (2008) Sildenafil acts on the central nervous system increasing sympathetic activity. J Appl Physiol 104:1683\u20139","journal-title":"J Appl Physiol"},{"key":"698_CR10","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/chir.530040304","volume":"4","author":"M Fujimaki","year":"1992","unstructured":"Fujimaki M (1992) Stereoselective disposition and tissue distribution of carvedilol enantiomers in rats. Chirality 4:148\u2013154","journal-title":"Chirality"},{"key":"698_CR11","doi-asserted-by":"crossref","DOI":"10.1201\/b14095","volume-title":"Pharmacokinetics","author":"M Gibaldi","year":"1982","unstructured":"Gibaldi M, Perrier D (1982) Pharmacokinetics, 2nd edn. Marcel Dekker, New York","edition":"2"},{"issue":"Suppl 4","key":"698_CR12","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1097\/00005344-199118041-00006","volume":"18","author":"H Hashimoto","year":"1991","unstructured":"Hashimoto H, Kanda A, Hubo H, Tanaka M (1991) Features of the acute hypotensive action of carvedilol and its ameliorating effect on myocardial ischemia. J Cardiovasc Pharmacol 18(Suppl 4):S22\u2013S28","journal-title":"J Cardiovasc Pharmacol"},{"key":"698_CR13","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s00210-006-0078-x","volume":"373","author":"C H\u00f6cht","year":"2006","unstructured":"H\u00f6cht C, Di Verniero C, Opezzo JA, Bramuglia GF, Taira CA (2006) Pharmacokinetic-pharmacodynamic (PK\u2013PD) modeling of cardiovascular effects of metoprolol in spontaneously hypertensive rats: a microdialysis study. Naunyn Schmiedebergs Arch Pharmacol 373:310\u2013318","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"698_CR14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2174\/157340208786241273","volume":"4","author":"C H\u00f6cht","year":"2008","unstructured":"H\u00f6cht C, Mayer MA, Opezzo JAW, Bertera FM, Taira CA (2008) Pharmacokinetic-pharmacodynamic modeling of antihypertensive drugs: from basic research to clinical practice. Curr Hypertens Rev 4:289\u2013302","journal-title":"Curr Hypertens Rev"},{"key":"698_CR15","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1586\/ecp.10.44","volume":"3","author":"C H\u00f6cht","year":"2010","unstructured":"H\u00f6cht C, Bertera FM, Taira CA (2010a) Importance of blood pressure variability in the assessment of cardiovascular risk and benefits of antihypertensive therapy. Expert Rev Clin Pharmacol 3:617\u2013621","journal-title":"Expert Rev Clin Pharmacol"},{"key":"698_CR16","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1517\/17425250903397381","volume":"6","author":"C H\u00f6cht","year":"2010","unstructured":"H\u00f6cht C, Bertera FM, Mayer MA, Taira CA (2010b) Issues in drug metabolism of major antihypertensive drugs: beta-blockers, calcium channel antagonists and angiotensin receptor blockers. Expert Opin Drug Metab Toxicol 6:199\u2013211","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"698_CR17","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/jps.2600761203","volume":"76","author":"JR Isanta","year":"1987","unstructured":"Isanta JR, Lasheras B, Fos D, Cenarruzabeitia E (1987) Comparative diltiazem plasma clearance in normotensive and hypertensive rats. J Pharm Sci 76:862\u2013865","journal-title":"J Pharm Sci"},{"key":"698_CR18","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1248\/bpb.31.1297","volume":"31","author":"K Ishida","year":"2008","unstructured":"Ishida K, Taira S, Morishita H, Kayano Y, Taguchi M, Hashimoto Y (2008) Stereoselective oxidation and glucuronidation of carvedilol in human liver and intestinal microsomes. Biol Pharm Bull 31:1297\u20131300","journal-title":"Biol Pharm Bull"},{"key":"698_CR19","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1161\/01.HYP.14.5.501","volume":"14","author":"HJ Jacob","year":"1989","unstructured":"Jacob HJ, Alper RH, Brody J (1989) Lability of arterial pressure after baroreceptor denervation is not pressure dependent. Hypertension 14:501\u2013510","journal-title":"Hypertension"},{"key":"698_CR20","doi-asserted-by":"crossref","first-page":"H62","DOI":"10.1152\/ajpcell.1995.269.1.C163","volume":"269","author":"BJ Janssen","year":"1995","unstructured":"Janssen BJ, Oosting J, Slaaf DW, Persson PB, Struijker-Boudier HA (1995) Hemodynamic basis of oscillations in systemic arterial pressure in conscious rats. Am J Physiol 269:H62\u2013H71","journal-title":"Am J Physiol"},{"key":"698_CR21","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/01.hjh.0000226203.57818.88","volume":"24","author":"CY Miao","year":"2006","unstructured":"Miao CY, Xie HH, Zhan LS, Su DF (2006) Blood pressure variability is more important than blood pressure level in determination of end-organ damage in rats. J Hypertens 24:1125\u20131135","journal-title":"J Hypertens"},{"issue":"Suppl. 2","key":"698_CR22","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1007\/BF01409476","volume":"38","author":"G Neugebauer","year":"1990","unstructured":"Neugebauer G, Akpan W, Kaufmann B, Reiff K (1990) Stereoselective disposition of carvedilol in man after intravenous and oral administration of the racemic compound. Eur J Clin Pharmacol 38(suppl 2):S108\u2013S111","journal-title":"Eur J Clin Pharmacol"},{"key":"698_CR23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1472-8206.1991.tb00698.x","volume":"5","author":"AJ Nichols","year":"1991","unstructured":"Nichols AJ, Gellai M, Ruffolo RR Jr (1991) Studies on the mechanism of arterial vasodilation produced by the novel antihypertensive agent, carvedilol. Fundam Clin Pharmacol 5:25\u201338","journal-title":"Fundam Clin Pharmacol"},{"key":"698_CR24","first-page":"H66","volume":"273","author":"J Oosting","year":"1997","unstructured":"Oosting J, Struijker-Boudier HA, Janssen BJ (1997) Circadian and ultradian control of cardiac output in spontaneous hypertension in rats. Am J Physiol 273:H66\u2013H75","journal-title":"Am J Physiol"},{"issue":"Suppl. 1","key":"698_CR25","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1097\/01.hjh.0000165624.79933.d3","volume":"23","author":"G Parati","year":"2005","unstructured":"Parati G (2005) Blood pressure variability: its measurement and significance in hypertension. J Hypertens 23(suppl 1):S19\u2013S25","journal-title":"J Hypertens"},{"key":"698_CR26","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/BF02975853","volume":"27","author":"NT Phuong","year":"2004","unstructured":"Phuong NT, Lee BJ, Choi JK, Kang JS, Kwon KI (2004) Enantioselective pharmacokinetics of carvedilol in human volunteers. Arch Pharm Res 27:973\u2013977","journal-title":"Arch Pharm Res"},{"key":"698_CR27","doi-asserted-by":"crossref","first-page":"381","DOI":"10.33549\/physiolres.932189","volume":"60","author":"M Pint\u00e9rov\u00e1","year":"2011","unstructured":"Pint\u00e9rov\u00e1 M, Kune\u0161 J, Zicha J (2011) Altered neural and vascular mechanisms in hypertension. Physiol Res 60:381\u2013402","journal-title":"Physiol Res"},{"key":"698_CR28","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1203\/01.PDR.0000127012.37315.36","volume":"55","author":"P Pladys","year":"2004","unstructured":"Pladys P, Lahaie I, Cambonie G, Thibault G, L\u00ea NL, Abran D, Nuyt AM (2004) Role of brain and peripheral angiotensin II in hypertension and altered arterial baroreflex programmed during fetal life in rat. Pediatr Res 55:1042\u20131049","journal-title":"Pediatr Res"},{"key":"698_CR29","first-page":"R58","volume":"273","author":"P Ponchon","year":"1997","unstructured":"Ponchon P, Elghozi JL (1997) Contribution of humoral systems to the short-term variability of blood pressure after severe hemorrhage. Am J Physiol 273:R58\u2013R69","journal-title":"Am J Physiol"},{"key":"698_CR30","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1474-4422(10)70066-1","volume":"9","author":"PM Rothwell","year":"2010","unstructured":"Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahl\u00f6f B, Poulter NR, Sever PS, ASCOT-BPLA and MRC Trial Investigators (2010) Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol 9:469\u2013480","journal-title":"Lancet Neurol"},{"issue":"Suppl. 2","key":"698_CR31","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1007\/BF01409471","volume":"38","author":"RR Ruffolo Jr","year":"1990","unstructured":"Ruffolo RR Jr, Gellai M, Hieble JP, Willette RN, Nichols AJ (1990) The pharmacology of carvedilol. Eur J Clin Pharmacol 38(suppl 2):S82\u2013S88","journal-title":"Eur J Clin Pharmacol"},{"key":"698_CR32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.autneu.2008.01.001","volume":"139","author":"HC Souza","year":"2008","unstructured":"Souza HC, Martins-Pinge MC, Dias da Silva VJ, Borghi-Silva A, Gastaldi AC, Blanco JH, Tezini GC (2008) Heart rate and arterial pressure variability in the experimental renovascular hypertension model in rats. Auton Neurosci 139:38\u201345","journal-title":"Auton Neurosci"},{"key":"698_CR33","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/ardp.19933260907","volume":"326","author":"E Stahl","year":"1993","unstructured":"Stahl E, Mutschler E, Baumgartner U, Spahn-Langguth H (1993) Carvedilol stereopharmacokinetics in rats: affinities to blood constituents and tissues. Arch Pharm (Weinheim) 326:529\u2013533","journal-title":"Arch Pharm (Weinheim)"},{"key":"698_CR34","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1440-1681.2007.04588.x","volume":"34","author":"HM Stauss","year":"2007","unstructured":"Stauss HM (2007) Identification of blood pressure control mechanisms by power spectral analysis. Clin Exp Pharmacol Physiol 34:362\u2013388","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"698_CR35","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1046\/j.1440-1681.2001.03508.x","volume":"28","author":"DF Su","year":"2001","unstructured":"Su DF, Miao CY (2001) Blood pressure variability and organ damage. Clin Exp Pharmacol Physiol 28:709\u2013715","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"698_CR36","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0022-3565(25)22055-9","volume":"227","author":"N Terao","year":"1983","unstructured":"Terao N, Shen DD (1983) Alterations in serum protein binding and pharmacokinetics of l-propranolol in the rat elicited by the presence of an indwelling venous catheter. J Pharmacol Exp Ther 227:369\u2013375","journal-title":"J Pharmacol Exp Ther"},{"key":"698_CR37","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1185\/03007995.2011.562884","volume":"27","author":"B Tomlinson","year":"2011","unstructured":"Tomlinson B, Dalal JJ, Huang J, Low LP, Park CG, Rahman AR, Reyes EB, Soenarta AA, Heagerty A, Follath F (2011) The role of \u03b2-blockers in the management of hypertension: an Asian perspective. Curr Med Res Opin 27:1021\u20131033","journal-title":"Curr Med Res Opin"},{"key":"698_CR38","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1161\/01.HYP.11.4.376","volume":"11","author":"J Tsoporis","year":"1988","unstructured":"Tsoporis J, Leenen FH (1988) Effect of arterial vasodilators on cardiac hypertrophy and sympathetic activity in rats. Hypertension 11:376\u2013386","journal-title":"Hypertension"},{"key":"698_CR39","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00228-008-0553-z","volume":"64","author":"RK Verbeeck","year":"2008","unstructured":"Verbeeck RK (2008) Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction. Eur J Clin Pharmacol 64:1147\u20131461","journal-title":"Eur J Clin Pharmacol"},{"key":"698_CR40","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/0009-9236(95)90036-5","volume":"57","author":"HH Zhou","year":"1995","unstructured":"Zhou HH, Wood AJ (1995) Stereoselective disposition of carvedilol is determined by CYP2D6. Clin Pharmacol Ther 57:518\u2013524","journal-title":"Clin Pharmacol Ther"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-011-0698-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-011-0698-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-011-0698-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T18:09:50Z","timestamp":1741889390000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-011-0698-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,3]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["698"],"URL":"https:\/\/doi.org\/10.1007\/s00210-011-0698-7","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"type":"print","value":"0028-1298"},{"type":"electronic","value":"1432-1912"}],"subject":[],"published":{"date-parts":[[2011,11,3]]}}}